Literature DB >> 9722503

Physical and functional interaction of SMADs and p300/CBP.

C Pouponnot1, L Jayaraman, J Massagué.   

Abstract

SMADs are transforming growth factor beta (TGF-beta) receptor substrates and mediators of TGF-beta transcriptional responses. Here we provide evidence that the coactivators p300 and CBP interact with Smads 1 through 4. The biological relevance of this interaction is shown in vivo by overexpression of the adenovirus E1A protein and mutant forms of E1A that lack p300-binding sites. Wild-type E1A, but not the mutants, inhibits SMAD-dependent transcriptional responses to TGF-beta. E1A also inhibits the intrinsic transactivating function of the Smad4 MH2 domain. In addition, overexpression of p300 enhances SMAD-dependent transactivation. Our results suggest a role for p300/CBP in SMAD-mediated transcriptional activation and provide an explanation for the observed ability of E1A to interfere with TGF-beta action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722503     DOI: 10.1074/jbc.273.36.22865

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction.

Authors:  R H Kim; D Wang; M Tsang; J Martin; C Huff; M P de Caestecker; W T Parks; X Meng; R J Lechleider; T Wang; A B Roberts
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

3.  Swift is a novel BRCT domain coactivator of Smad2 in transforming growth factor beta signaling.

Authors:  K Shimizu; P Y Bourillot; S J Nielsen; A M Zorn; J B Gurdon
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.

Authors:  R P Nagarajan; F Chen; W Li; E Vig; M A Harrington; H Nakshatri; Y Chen
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

5.  The Smad3 linker region contains a transcriptional activation domain.

Authors:  Guannan Wang; Jianyin Long; Isao Matsuura; Dongming He; Fang Liu
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

6.  Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator.

Authors:  Tamaki Suganuma; Masahiro Kawabata; Tomoko Ohshima; Masa-Aki Ikeda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-17       Impact factor: 11.205

Review 7.  Cross-talk between nitric oxide and transforming growth factor-beta1 in malaria.

Authors:  Yoram Vodovotz; Ruben Zamora; Matthew J Lieber; Shirley Luckhart
Journal:  Curr Mol Med       Date:  2004-11       Impact factor: 2.222

8.  TGF-β regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes.

Authors:  Sangeeta Kowli; Rupa Velidandla; Kim E Creek; Lucia Pirisi
Journal:  Virology       Date:  2013-09-19       Impact factor: 3.616

9.  Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site.

Authors:  Kenji Ogawa; Feifei Chen; Chenzhong Kuang; Yan Chen
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

Review 10.  To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications.

Authors:  Katharine H Wrighton; Xin-Hua Feng
Journal:  Cell Signal       Date:  2008-02-15       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.